Berger Montague Investigates Hims & Hers After Stock Plunge and Novo Nordisk Split.
Berger Montague, a nationally known securities litigation firm, is investigating possible claims on behalf of investors in Hims & Hers Health, Inc. (NYSE: HIMS) after the company’s stock tumbled over 26% in a single day.
The drop came on June 23, when Novo Nordisk abruptly ended its partnership with Hims & Hers. The pharma giant accused the telehealth company of deceptive marketing and selling unapproved compounded versions of semaglutide, the active ingredient in GLP-1 drugs like Wegovy and Ozempic.
Hims & Hers had recently expanded into the GLP-1 weight loss drug space, promoting treatments tied to semaglutide, despite questions about how the medications were being sourced and marketed.
Berger Montague is investigating whether Hims & Hers and its executives misled investors by failing to disclose:
-
Regulatory concerns tied to compounded semaglutide
-
The risks involved with its GLP-1 offerings
-
The true nature of its deal with Novo Nordisk
If you bought HIMS stock and were affected by the June 23 crash, you may have legal options. To learn more about the investigation, please visit Berger Montague’s dedicated page here.
To learn more or speak with an attorney:
Andrew Abramowitz – aabramowitz@bm.net | 📞 (215) 875-3015
Peter Hamner – phamner@bm.net
Hims & Hers Health, Inc. is a publicly traded telehealth company (NYSE: HIMS) founded in 2017 and headquartered in San Francisco, California. The company provides accessible, digital-first healthcare services across the U.S. and UK, offering treatment for conditions related to sexual health, hair loss, dermatology, mental health, and weight management.
Through its platform, users can access licensed medical professionals, receive personalized treatment plans, and have prescription medications shipped directly to their homes. Hims & Hers emphasizes stigma-free, affordable care and has grown to serve over 1.5 million subscribers. In 2021, the company went public via a SPAC merger and has since expanded internationally, including through its acquisition of UK-based telehealth provider ZAVA.
Berger Montague is a prominent law firm founded in 1970, specializing in complex litigation, including class actions, antitrust, and consumer protection cases. Headquartered in Philadelphia, Pennsylvania, the firm has a nationwide presence and is known for securing significant legal victories. Berger Montague represents consumers, investors, and employees, recovering billions of dollars in high-profile cases. With a team of skilled attorneys, the firm is dedicated to achieving justice through strategic advocacy and extensive resources, earning recognition for its expertise and commitment to clients.
More Articles from Lawyer Monthly
